Advances in Duration of Untreated Psychosis and Its Early Intervention

doi:10.12114/j.issn.1007-9572.2023.0200

Abstract

Abstract:

Mental illness usually involves a range of cognitive, behavioral, and affective symptoms associated with impaired occupational or social functioning. Duration of untreated psychosis (DUP) is considered as an important predictor and independent risk factor for the prognosis of patients with mental disorders, a longer DUP is associated with poor prognosis. Meanwhile, early intervention measures to shorten DUP have gradually attracted increasing attention from both domestic and international researchers. In this paper, the related studies on DUP were reviewed and analyzed, the concept, measurement tools, neurobiological mechanisms of DUP, the relationship between DUP and prognosis, and early intervention measures to shorten DUP were described, in order to provide ideas and reference for developing clinical intervention strategies for DUP.

Key words: Mental disorders, Schizophrenia, Duration of untreated psychosis, Early medical intervention, Prognosis, Review

摘要：

精神病通常涉及一系列与职业或社会功能受损有关的认知、行为和情感症状。未治期是影响精神病患者预后的重要预测因素和独立危险因素，较长的未治期与疾病不良预后相关，缩短未治期的早期干预措施也逐渐受到国内外研究者的关注。本文回顾分析了精神病未治期的相关研究，阐述了未治期的概念、测量工具、神经生物学机制、未治期与精神病预后的关系及缩短未治期的早期干预措施，为临床针对精神病未治期的相关干预策略提供思路和依据。

关键词: 精神障碍, 精神分裂症, 未治期, 早期医疗干预, 预后, 综述

ZHANG Siyu,ZHOU Yuqiu,DU Xiaohui, et al. Advances in Duration of Untreated Psychosis and Its Early Intervention[J]. Chinese General Practice, 2023, 26(33): 4110-4117. DOI: 10.12114/j.issn.1007-9572.2023.0200.
张思宇,周郁秋,杜晓慧等. 精神病未治期及其早期干预的研究进展[J]. 中国全科医学, 2023, 26(33): 4110-4117. DOI: 10.12114/j.issn.1007-9572.2023.0200.

References 58

[1]	FUSAR-POLI P, MCGORRY P D, KANE J M. Improving outcomes of first-episode psychosis：an overview[J]. World Psychiatry，2017,16(3):251-265. DOI：10.1002/wps.20446.
[2]	HUANG Y, WANG Y, WANG H，et al. Prevalence of mental disorders in China：a cross-sectional epidemiological study[J]. Lancet Psychiatry，2019,6(3):211-224. DOI：10.1016/S2215-0366(18)30511-X.
[3]	李从红，施忠英. 精神病病人照顾者心理健康状况及其影响因素[J]. 护理研究，2021,35(15):2757-2760. DOI：10.12102/j.issn.1009-6493.2021.15.027.
[4]	PERKINS D O, GU H B, BOTEVA K，et al. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia：a critical review and meta-analysis[J]. Am J Psychiatry，2005,162(10):1785-1804. DOI：10.1176/appi.ajp.162.10.1785.
[5]	O'KEEFFE D, KINSELLA A, WADDINGTON J L，et al. 20-year prospective，sequential follow-up study of heterogeneity in associations of duration of untreated psychosis with symptoms，functioning，and quality of life following first-episode psychosis[J]. Am J Psychiatry，2022,179(4):288-297. DOI：10.1176/appi.ajp.2021.20111658.
[6]	GOFF D C, ZENG B T, ARDEKANI B A，et al. Association of hippocampal atrophy with duration of untreated psychosis and molecular biomarkers during initial antipsychotic treatment of first-episode psychosis[J]. JAMA Psychiatry，2018,75(4):370. DOI：10.1001/jamapsychiatry.2017.4595.
[7]	STONE W S, CAI B, LIU X H，et al. Association between the duration of untreated psychosis and selective cognitive performance in community-dwelling individuals with chronic untreated schizophrenia in rural China[J]. JAMA Psychiatry，2020,77(11):1116-1126. DOI：10.1001/jamapsychiatry.2020.1619.
[8]	ITO S, NEMOTO T, TSUJINO N，et al. Differential impacts of duration of untreated psychosis（DUP） on cognitive function in first-episode schizophrenia according to mode of onset[J]. Eur Psychiatry，2015,30(8):995-1001. DOI：10.1016/j.eurpsy.2015.08.004.
[9]	HOWES O D, WHITEHURST T, SHATALINA E，et al. The clinical significance of duration of untreated psychosis：an umbrella review and random-effects meta-analysis[J]. World Psychiatry，2021,20(1):75-95. DOI：10.1002/wps.20822.
[10]	王继军，朱紫青，李春波，等. 精神分裂症未治期及其影响因素研究[J]. 上海精神医学，2009,21(1):10-15. DOI：10.3969/j.issn.1002-0829.2009.01.003.
[11]	GOLAY P, ALAMEDA L, BAUMANN P，et al. Duration of untreated psychosis：impact of the definition of treatment onset on its predictive value over three years of treatment[J]. J Psychiatr Res，2016,77:15-21. DOI：10.1016/j.jpsychires.2016.02.017.
[12]	POLARI A, BERK M, MACNEIL C，et al. Duration of untreated psychosis：what are we talking about?[J]. Acta Neuropsychiatr，2009,21(3):106-108. DOI：10.1111/j.1601-5215.2009.00380.x.
[13]	NORMAN R M G, MALLA A K. Duration of untreated psychosis：a critical examination of the concept and its importance[J]. Psychol Med，2001,31(3):381-400. DOI：10.1017/s0033291701003488.
[14]	BERTOLOTE J, MCGORRY P. Early intervention and recovery for young people with early psychosis：consensus statement[J]. Br J Psychiatry Suppl，2005,48:s116-119. DOI：10.1192/bjp.187.48.s116.
[15]	PERKINS D O, LESERMAN J, JARSKOG L F，et al. Characterizing and dating the onset of symptoms in psychotic illness：the Symptom Onset in Schizophrenia（SOS） inventory[J]. Schizophr Res，2000,44(1):1-10. DOI：10.1016/s0920-9964(99)00161-9.
[16]	SINGH S P, COOPER J E, FISHER H L，et al. Determining the chronology and components of psychosis onset：the Nottingham Onset Schedule（NOS）[J]. Schizophr Res，2005,80(1):117-130. DOI：10.1016/j.schres.2005.04.018.
[17]	HÄFNER H, RIECHER-RÖSSLER A, HAMBRECHT M，et al. IRAOS：an instrument for the assessment of onset and early course of schizophrenia[J]. Schizophr Res，1992,6(3):209-223. DOI：10.1016/0920-9964(92)90004-o.
[18]	BEISER M, ERICKSON D, FLEMING J A，et al. Establishing the onset of psychotic illness[J]. Am J Psychiatry，1993,150(9):1349-1354. DOI：10.1176/ajp.150.9.1349.
[19]	KAY S R, OPLER L A, LINDENMAYER J P. The positive and negative syndrome scale（PANSS）：rationale and standardisation[J]. Br J Psychiatry，1989,155(S7):59-65. DOI：10.1192/s0007125000291514.
[20]	何燕玲，张明园. 阳性和阴性综合征量表（PANSS）及其应用[J]. 临床精神医学杂志，1997,7(6):353-355.
[21]	司天梅，杨建中，舒良，等. 阳性和阴性症状量表（PANSS，中文版）的信、效度研究[J]. 中国心理卫生杂志，2004,18(1):45-47. DOI：10.3321/j.issn:1000-6729.2004.01.016.
[22]	LEWIS D A, LIEBERMAN J A. Catching up on schizophrenia[J]. Neuron，2000,28(2):325-334. DOI：10.1016/s0896-6273(00)00111-2.
[23]	CRESPO-FACORRO B, ROIZ-SANTIÁÑEZ R, PELAYO-TERÁN J M，et al. Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia[J]. Schizophr Res，2007,91(1/2/3):87-96. DOI：10.1016/j.schres.2006.12.015.
[24]	KESHAVAN M S, HAAS G L, KAHN C E，et al. Superior temporal gyrus and the course of early schizophrenia：progressive，static，or reversible?[J]. J Psychiatr Res，1998,32(3/4):161-167. DOI：10.1016/s0022-3956(97)00038-1.
[25]	ANDERSON K K, RODRIGUES M, MANN K，et al. Minimal evidence that untreated psychosis damages brain structures：a systematic review[J]. Schizophr Res，2015,162(1/2/3):222-233. DOI：10.1016/j.schres.2015.01.021.
[26]	ZOGHBI A W, LIEBERMAN J A, GIRGIS R R. The neurobiology of duration of untreated psychosis：a comprehensive review[J]. Mol Psychiatry，2023,28(1):168-190. DOI：10.1038/s41380-022-01718-0.
[27]	COMPTON M T, GORDON T L, WEISS P S，et al. The "doses" of initial，untreated hallucinations and delusions：a proof-of-concept study of enhanced predictors of first-episode symptomatology and functioning relative to duration of untreated psychosis[J]. J Clin Psychiatry，2011,72(11):1487-1493. DOI：10.4088/JCP.09m05841yel.
[28]	PENTTILÄ M, JÄÄSKELÄINEN E, HIRVONEN N，et al. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia：systematic review and meta-analysis[J]. Br J Psychiatry，2014,205(2):88-94. DOI：10.1192/bjp.bp.113.127753.
[29]	MCGLASHAN T H. Premorbid adjustment，onset types，and prognostic scaling：still informative?[J]. Schizophr Bull，2008,34(5):801-805. DOI：10.1093/schbul/sbn073.
[30]	LEWANDOWSKI K E, EACK S M, HOGARTY S S，et al. Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?[J]. Schizophr Res，2011,125(2/3):291-294. DOI：10.1016/j.schres.2010.11.017.
[31]	SOLE B, BONNIN C M, TORRENT C，et al. Neurocognitive impairment across the bipolar spectrum[J]. CNS Neurosci Ther，2012,18(3):194-200. DOI：10.1111/j.1755-5949.2011.00262.x.
[32]	ADDINGTON J, ADDINGTON D. Cognitive functioning in first-episode schizophrenia[J]. J Psychiatry Neurosci，2002,27(3):188-192. DOI：10.1034/j.1600-079X.2002.01878.x.
[33]	HEYDEBRAND G, WEISER M, RABINOWITZ J，et al. Correlates of cognitive deficits in first episode schizophrenia[J]. Schizophr Res，2004,68(1):1-9. DOI：10.1016/S0920-9964(03)00097-5.
[34]	CUESTA M J, GARCÍA DE JALÓN E, CAMPOS M S，et al. Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis[J]. Schizophr Res，2012,141(2/3):222-227. DOI：10.1016/j.schres.2012.08.019.
[35]	STONE W S, CAI B, LIU X H，et al. Association between the duration of untreated psychosis and selective cognitive performance in community-dwelling individuals with chronic untreated schizophrenia in rural China[J]. JAMA Psychiatry，2020,77(11):1116-1126. DOI：10.1001/jamapsychiatry.2020.1619.
[36]	HEERAMUN-AUBEELUCK A, LIU N, FISCHER F，et al. Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia：a 1-year study[J]. Nord J Psychiatry，2015,69(4):254-261. DOI：10.3109/08039488.2014.929738.
[37]	GOLDBERG T E, BURDICK K E, MCCORMACK J，et al. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia[J]. Schizophr Res，2009,107(2/3):262-266. DOI：10.1016/j.schres.2008.11.003.
[38]	周亚楠，翟金国，陈敏. 首发精神分裂症精神病未治期对认知功能和社会功能的影响[J]. 中国神经精神病杂志，2018,44(1):38-43. DOI：10.3969/j.issn.1002-0152.2018.01.008.
[39]	GUMLEY A I, SCHWANNAUER M, MACBETH A，et al. Insight，duration of untreated psychosis and attachment in first-episode psychosis：prospective study of psychiatric recovery over 12-month follow-up[J]. Br J Psychiatry，2014,205(1):60-67. DOI：10.1192/bjp.bp.113.126722.
[40]	DASSA D, BOYER L, BENOIT M，et al. Factors associated with medication non-adherence in patients suffering from schizophrenia：a cross-sectional study in a universal coverage health-care system[J]. Aust N Z J Psychiatry，2010,44(10):921-928. DOI：10.3109/00048674.2010.493503.
[41]	KILLACKEY E, YUNG A R. Effectiveness of early intervention in psychosis[J]. Curr Opin Psychiatry，2007,20(2):121-125. DOI：10.1097/YCO.0b013e328017f67d.
[42]	MCGLASHAN T H, ZIPURSKY R B, PERKINS D，et al. Randomized，double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis[J]. Am J Psychiatry，2006,163(5):790-799. DOI：10.1176/ajp.2006.163.5.790.
[43]	PRETI A, RABALLO A, MENEGHELLI A，et al. Antipsychotics are related to psychometric conversion to psychosis in ultra-high-risk youth[J]. Early Interv Psychiatry，2022,16(4):342-351. DOI：10.1111/eip.13158.
[44]	ZHANG T H, XU L H, TANG X C，et al. Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP（ShangHai At Risk for Psychosis）[J]. Aust N Z J Psychiatry，2020,54(7):696-706. DOI：10.1177/0004867420917449.
[45]	PRUESSNER M, IYER S N, FARIDI K，et al. Stress and protective factors in individuals at ultra-high risk for psychosis，first episode psychosis and healthy controls[J]. Schizophr Res，2011,129(1):29-35. DOI：10.1016/j.schres.2011.03.022.
[46]	CORRELL C U, HAUSER M, AUTHER A M，et al. Research in people with psychosis risk syndrome：a review of the current evidence and future directions[J]. J Child Psychol Psychiatry，2010,51(4):390-431. DOI：10.1111/j.1469-7610.2010.02235.x.
[47]	张思宇，周郁秋，王正君，等. 精神分裂症超高危人群的早期心理干预与精神分裂症转化关系的meta分析[J]. 中国心理卫生杂志，2021,35(4):290-299. DOI：10.3969/j.issn.1000-6729.2021.04.005.
[48]	POZZA A, DÈTTORE D. Modular cognitive-behavioral therapy for affective symptoms in young individuals at ultra-high risk of first episode of psychosis：Randomized controlled trial[J]. J Clin Psychol，2020,76(3):392-405. DOI：10.1002/jclp.22901.
[49]	秦丽颖，张艳梅，许俊杰. 计算机认知矫正治疗对精神分裂症超高危人群的认知功能、症状及转化的影响[J]. 神经疾病与精神卫生，2019,19(1):60-64. DOI：10.3969/j.issn.1009-6574.2019.01.016.
[50]	AMMINGER G P, SCHÄFER M R, PAPAGEORGIOU K，et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders：a randomized，placebo-controlled trial[J]. Arch Gen Psychiatry，2010,67(2):146-154. DOI：10.1001/archgenpsychiatry.2009.192.
[51]	AMMINGER G P, NELSON B, MARKULEV C，et al. The NEURAPRO biomarker analysis：long-chain Omega-3 fatty acids improve 6-month and 12-month outcomes in youths at ultra-high risk for psychosis[J]. Biol Psychiatry，2020,87(3):243-252. DOI：10.1016/j.biopsych.2019.08.030.
[52]	CHAN S K W, CHAU E H S, HUI C L M，et al. Long term effect of early intervention service on duration of untreated psychosis in youth and adult population in Hong Kong[J]. Early Interv Psychiatry，2018,12(3):331-338. DOI：10.1111/eip.12313.
[53]	CONNOR C, BIRCHWOOD M, FREEMANTLE N，et al. Don't turn your back on the symptoms of psychosis：the results of a proof-of-principle，quasi-experimental intervention to reduce duration of untreated psychosis[J]. BMC Psychiatry，2016,16:127. DOI：10.1186/s12888-016-0816-7.
[54]	PADILLA E, MOLINA J, KAMIS D，et al. The efficacy of targeted health agents education to reduce the duration of untreated psychosis in a rural population[J]. Schizophr Res，2015,161(2/3):184-187. DOI：10.1016/j.schres.2014.10.039.
[55]	POWER P, IACOPONI E, REYNOLDS N，et al. The Lambeth Early Onset Crisis Assessment Team Study：general practitioner education and access to an early detection team in first-episode psychosis[J]. Br J Psychiatry Suppl，2007,51:s133-139. DOI：10.1192/bjp.191.51.s133.
[56]	MELLE I, LARSEN T K, HAAHR U，et al. Reducing the duration of untreated first-episode psychosis：effects on clinical presentation[J]. Arch Gen Psychiatry，2004,61(2):143-150. DOI：10.1001/archpsyc.61.2.143.
[57]	HEGELSTAD W T, LARSEN T K, AUESTAD B，et al. Long-term follow-up of the TIPS early detection in psychosis study：effects on 10-year outcome[J]. Am J Psychiatry，2012,169(4):374-380. DOI：10.1176/appi.ajp.2011.11030459.
[58]	OLIVER D, DAVIES C, CROSSLAND G，et al. Can we reduce the duration of untreated psychosis? A systematic review and meta-analysis of controlled interventional studies[J]. Schizophr Bull，2018,44(6):1362-1372. DOI：10.1093/schbul/sbx166.